EUVIMEDOpdag EUVIMED
Multizentrische StudieBeobachtungsstudieKohortenstudieOpen access · CC BY 4.0

Continuous use of direct oral anticoagulants during and after simple and surgical tooth extractions: a prospective clinical cohort study

Krister Johansson, Jonas P Becktor, Aron Naimi-Akbar, Peter J Svensson, Bengt Götrick

BMC Oral Health · 2025

DOI: 10.1186/s12903-025-05949-9 ↗

At a glance

Multizentrische Studie in BMC Oral Health, 2025. Written by Krister Johansson and 4 co-authors. Institution: Department of Oral and Maxillofacial Surgery and Oral Medicine, Faculty of Odontology, Malmö University, Malmö, Sweden. krister.johansson@mau.se. Major MEDLINE topics: Anticoagulants, Postoperative Hemorrhage, Tooth Extraction. Cited 5 times so far (Crossref); 20 references. The full text is freely available (open access, CC BY 4.0). Funded by: Malmö University.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background

No consistent approach to the management of direct oral anticoagulants (DOACs) during and after oral surgery has been established. Thus, DOACs may be unnecessarily discontinued, raising the potential risk of life-threatening thromboembolism. To address the inconsistency in this approach, our study assessed the risk of bleeding and other complications in patients who continue to use DOACs during and after simple and surgical tooth extractions.

Methods

Between May 2016 and December 2023, this prospective study recruited patients aged 18 years or older who were receiving a DOAC or warfarin and were in need of simple or surgical extractions of one or more teeth. Local haemostatic agents were being used to control bleeding. Patients were instructed to manage minor postoperative bleeding at home by biting down on gauze soaked in tranexamic acid for at least 30 min. After surgery, all patients were followed for 7 days. The chi-squared test compared dichotomous variables; the two-sample t -test, continuous variables; logistic regressions, dichotomous outcomes; and linear regressions, continuous outcomes.

Results

In all, 354 teeth were extracted from 160 patients receiving DOACs and 56 patients receiving warfarin. The incidence of any type of postoperative bleeding was 27% in patients receiving DOACs and 37% in those receiving warfarin (OR 0.66, 95% CI: 0.28–1.57; p = 0.35). Most patients were able to manage any bleeding at home themselves. Clinically relevant bleeding necessitating prompt evaluation or a secondary surgical intervention by a dentist or healthcare professional occurred in 3% of patients receiving DOACs and 11% of patients receiving warfarin (OR 0.30, 95% CI: 0.08–1.06; p = 0.06). No reports of major bleeding requiring hospitalization or blood transfusion were found. Perioperative bleeding volume was comparable between the two groups.

Conclusions

Patients receiving DOACs without interruption during surgery may have a lower risk of bleeding than those on warfarin. Patients may safely continue to use DOACs during and after simple and surgical extractions. This eliminates the potentially higher risk of serious thromboembolic events that are associated with a pause in anticoagulant therapy. Clinical trial registration ClinicalTrials.gov (ID: NCT04662515). Retrospectively registered 4 December 2020.

Subjects

MeSH terms (MEDLINE)

AnticoagulantsPostoperative HemorrhageTooth ExtractionAdultAgedAged, 80 and overFemaleHumansMaleMiddle AgedAdministration, OralProspective StudiesWarfarin

Author keywords

AnticoagulantsDirect oral anticoagulantsFactor Xa inhibitorsOral haemorrhageOral surgical proceduresWarfarin

Substances

AnticoagulantsWarfarin

Authors and institutions

  • Department of Oral and Maxillofacial Surgery and Oral Medicine, Faculty of Odontology, Malmö University, Malmö, Sweden. krister.johansson@mau.se.
  • Department of Oral & Maxillofacial Surgery, Skåne University Hospital, Lund, Sweden. krister.johansson@mau.se.
  • Department of Oral and Maxillofacial Surgery and Oral Medicine, Faculty of Odontology, Malmö University, Malmö, Sweden.
  • Health Technology Assessment-Odontology (HTA-O), Faculty of Odontology, Malmö University, Malmö, Sweden.
  • Department of Translational Medicine, Clinical Coagulation Research Unit, Skåne University Hospital, Malmö, Sweden.
  • Department of Orofacial medicine, Faculty of Odontology, Malmö University, Malmö, Sweden.

Funding

  • Malmö University

Cite

APA

Johansson, K., Becktor, J. P., Naimi-Akbar, A., Svensson, P. J., & Götrick, B. (2025). Continuous use of direct oral anticoagulants during and after simple and surgical tooth extractions: a prospective clinical cohort study. BMC Oral Health. https://doi.org/10.1186/s12903-025-05949-9

Vancouver

Johansson K, Becktor JP, Naimi-Akbar A, Svensson PJ, Götrick B. Continuous use of direct oral anticoagulants during and after simple and surgical tooth extractions: a prospective clinical cohort study. BMC Oral Health. 2025. doi:10.1186/s12903-025-05949-9

BibTeX
@article{Johansson2025,
  author = {Johansson, Krister and Becktor, Jonas P and Naimi-Akbar, Aron and Svensson, Peter J and Götrick, Bengt},
  title = {Continuous use of direct oral anticoagulants during and after simple and surgical tooth extractions: a prospective clinical cohort study},
  journal = {BMC Oral Health},
  year = {2025},
  doi = {10.1186/s12903-025-05949-9}
}
Start for free →